Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Maron-Gutierrez, R. Castiglione, C. Barbosa, D. Xisto, M. Oliveira, C. Takiya, P. Rocco, M. Morales (Rio de Janeiro, Brazil). Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis. Eur Respir J 2008; 32: Suppl. 52, 4435

Member's Comments

No comment yet.

Related content which might interest you: Effects of bone marrow mononuclear cell therapy in an experimental model of acute lung injury Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The contribution of bone marrow derived progenitor cells to lung remodelling Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008 Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Investigation of the participation of bone marrow derived cells in pulmonary angiogenesis and vascular remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 481s Year: 2002 Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 Monitoring of lung function and airways inflammation after bone marrow transplantation Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits Source: Eur Respir J 2004; 24: Suppl. 48, 720s Year: 2004 Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006 Impact of bone marrow mononuclear cell administration route on lung and distal organs in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Intratracheal versus intravenous bone marrow mononuclear cell therapy in pulmonary and extrapulmonary acute lung injury: Which is the best administration route? Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury Year: 2010 Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis Source: Eur Respir J 2011; 37: 1217-1225 Year: 2011